Femasys
Manufacturing · Georgia, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
3950 Johns Creek Ct Ste 100, Suwanee, Ge...Phone Number
(877) 336-2562Website
www.femasys.comRevenue
<$5 MillionStock Symbol
FEMYIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Femasys
Femasys Inc., a biomedical company, develops therapeutic and diagnostic solutions to address unmet women healthcare needs worldwide. The company provides FemVue saline-air device, a contrast-generating product in the United States, Canada, Japan, and Hong Kong; FemCath, a cornual balloon catheter, a single intrauterine directional delivery product that allows for selective evaluation of an individual fallopian tube; and FemCerv, a biopsy device for endocervical curettage, which can be used to sample cervical cells and tissue circumferentially with sample containment within the device to minimize contamination. It also develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; and FemEMB, a product candidate for endometrial sampling in support of uterine cancer detection testing. The company offers its products to reproductive endocrinologists for infertility products, obstetrics-gynecological physicians, related healthcare prRead more
Femasys Org Chart
Get the full picture
Sign in to uncover key details.
MH
Vice President, Manufacturing
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Femasys your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Click to see if Femasys had a recent Job posting/layoffs
Product Launch: Get notified when Femasys launches new products
Funding: Get notified immidiatlly once Femasys has new funding data
Congratulate Masked Content for being promoted to Masked Content at Femasys
Check if Femasys has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Femasys recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Femasys, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Femasys is spiking on competitors!
Recommended Actions
Find VP level buyers at Femasys
Find 2 more new buyers
Compare Similar Companies to Femasys
Compare insights from companies similar to Femasys, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Femasys is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Femasys is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Femasys.
Femasys financials insights
Gather financial insights about Femasys, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2012
Private Equity
$1M
2015
Series B
$10.2M
2016
Private Equity
$3.3M
Series C
$40M
2020
Debt
$350K
2023
Other Financing Round
$5M
2025
Stock/Share Issuance
$10M
Stock/Share Issuance
$12M
2026
Stock/Share Issuance
$30M
Femasys Tech Stack
A closer look at the technologies used by Femasys
Most Recent Scoops
Funding
Funding
Earnings
Earnings, Finance
Earnings
Earnings, Finance
Person-Based
Finance, Investor Relations
Person-Based
Compliance
Femasys News & Media
Femasys Partners with CapexMD to Expand Patient Access to FemaSeed® Fertility Portfolio
Collaboration provides dedicated patient financing for Femasys fertility solutions, helping reduce financial barriers to care across OB/GYN practices and fertility centers Collaboration provides dedicated patient financing for Femasys fertility solutions, helping reduce financial barriers to care across OB/GYN practices and fertility centersFemasys Partners with UNC Health to Introduce Its FemaSeed® Fertility Portfolio Across Statewide OB/GYN Care Locations
-- For the first time, OB/GYNs within the UNC Health system will be able to offer women FemVue® fertility evaluation and FemaSeed as a first-line treatment option -- ATLANTA, Aug. 26, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator developing transformative fertility and non-surgical permanent birth control solutions designed to improve the standard of care, expand access, and reduce costs for women worldwide, announced today a partnership with UNC Health toFemasys Announces FDA Approval of Modular PMA Submission Approach for FemBloc®
-- Modular PMA pathway advances FemBloc toward potential U.S. approval while Femasys builds commercial infrastructure across its reproductive health portfolio -- -- Modular PMA pathway advances FemBloc toward potential U.S. approval while Femasys builds commercial infrastructure across its reproductive health portfolio --Femasys Announces Financial Results for Quarter Ended June 30, 2026 and Provides Corporate Update
-- $30 million financing enables execution of U.S. commercial strategy for the FemaSeed® fertility portfolio and advancement of the FemBloc® clinical and regulatory program toward U.S. approval -- ATLANTA, Aug. 14, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator developing transformative fertility and non-surgical permanent birth control solutions designed to improve the standard of care, expand access, and reduce costs for women worldwide, announces its fina
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Femasys
Sign Up For FreeTo access detailed company insights
Femasys Inc., a biomedical company, develops therapeutic and diagnostic solutions to address unmet women healthcare needs worldwide. The company provides FemVue saline-air device, a contrast-generating product in the United States, Canada, Japan, and Hong Kong; FemCath, a cornual balloon catheter, a single intrauterine directional delivery product... Read More
